Testing effectiveness (Phase 2)Ended earlyNCT00346151
What this trial is testing
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Who this might be right for
Renal Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 5